Search Results - "Neubauer, B L"

Refine Results
  1. 1

    Growth Regulation of Prostatic Stromal Cells by Prostate-Specific Antigen by Sutkowski, Debra M., Goode, Robin L., Baniel, Jack, Teater, Carroll, Cohen, Pinchas, McNulty, Ann M., Hsiung, Hansen M., Becker, Gerald W., Neubauer, Blake Lee

    “…BACKGROUND: Prostate-specific antigen (PSA) is a serine protease that can cleave insulin-like growth factor-binding protein-3 (IGFBP3), thereby decreasing its…”
    Get full text
    Journal Article
  2. 2
  3. 3

    LY191704: A Selective, Nonsteroidal Inhibitor of Human Steroid 5α- Reductase Type 1 by Hirsch, Kenneth S., Jones, Charles D., Audia, James E., Andersson, Stefan, McQuaid, Loretta, Stamm, Nancy B., Neubauer, Blake L., Pennington, Pam, Toomey, Richard E., Russell, David W.

    “…Androgens, in particular dihydrotestosterone (DHT), play a key role in differentiation, growth, and maintenance of the mammalian prostate. Production of DHT…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Epithelial-Mesenchymal Interactions in Prostatic Development. I. Morphological Observations of Prostatic Induction by Urogenital Sinus Mesenchyme in Epithelium of the Adult Rodent Urinary Bladder by Cunha, Gerald R., Fujii, Hirohiko, Neubauer, Blake L., Shannon, John M., Sawyer, Linwood, Reese, Beth A.

    Published in The Journal of cell biology (01-06-1983)
    “…Tissue recombinants of embryonic urogenital sinus mesenchyme (UGM) and epithelium of the urinary bladder (urothelium, BLE) of adult rats and mice were grown…”
    Get full text
    Journal Article
  6. 6

    LY191704 inhibits type I steroid 5α-reductase in human scalp by NEUBAUER, B. L, GRAY, H. M, TINDALL, D. J, TOOMEY, R. E, YAO, R. C, AUDIA, J. E, HANKE, C. W, HIRSCH, K. S, HSIAO, K. C, JONES, C. D, KUMAR, M. V, LAWHORN, D. E, LINDZEY, J, MCQUAID, L

    “…Conversion of testosterone to dihydrotestosterone (DHT) has been demonstrated to be catalyzed by two isoforms of steroid 5 alpha-reductase, designated types I…”
    Get full text
    Journal Article
  7. 7

    AKT-1, -2, and -3 are Expressed in Both Normal and Tumor Tissues of the Lung, Breast, Prostate, and Colon by ZINDA, Michael J, JOHNSON, Mac A, GRAFF, Jeremy R, PAUL, Jonathan D, HORN, Candice, KONICEK, Bruce W, LU, Zhao Hai, SANDUSKY, George, THOMAS, James E, NEUBAUER, Blake Lee, LAI, Mei T

    Published in Clinical cancer research (01-08-2001)
    “…Purpose: The AKT/PKB kinase controls many of the intracellular processes that are dysregulated in human cancer, including the suppression of apoptosis and…”
    Get full text
    Journal Article
  8. 8

    Expression of Group IIa Secretory Phospholipase A2 Increases with Prostate Tumor Grade by GRAFF, Jeremy R, KONICEK, Bruce W, DEDDENS, James A, CHEDID, Marcio, HURST, Bernadette M, COLLIGAN, Bruce, NEUBAUER, Blake Lee, CARTER, Harry W, CARTER, Julia H

    Published in Clinical cancer research (01-12-2001)
    “…Purpose: Arachidonate release contributes to prostate tumor progression as arachidonate is metabolized into prostaglandins and leukotrienes, potent mediators…”
    Get full text
    Journal Article
  9. 9

    Ambulatory blood pressure monitoring during pregnancy. Establishment of standards of normalcy by Ferguson, J H, Neubauer, B L, Shaar, C J

    Published in American journal of hypertension (01-09-1994)
    “…Ambulatory blood pressure monitoring (ABPM) was used as an effective methodology by a primary care physician to assess normalcy of blood pressure (BP) and…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model by Neubauer, B L, Best, K L, Counts, D F, Goode, R L, Hoover, D M, Jones, C D, Sarosdy, M F, Shaar, C J, Tanzer, L R, Merriman, R L

    Published in The Prostate (01-10-1995)
    “…The benzothiophene antiestrogen, raloxifene (LY156758), has selective estrogen pharmacological antagonist activity in rats. The PAIII rat prostatic…”
    Get more information
    Journal Article
  12. 12

    Experimental induction of neoplasia in the accessory sex organs of male lobund-wistar rats by HOOVER, D. M, BEST, K. L, MCKENNEY, B. K, TAMURA, R. N, NEUBAUER, B. L

    Published in Cancer research (Chicago, Ill.) (1990)
    “…Experimental induction of neoplasia in the urogenital tract was studied in male Lobund-Wistar rats. Animals were given single 30.0-mg/kg i.v. injections of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984 by Neubauer, B L, Merriman, R L, Best, K L, Goode, R L, Sarosdy, M F, Tanzer, L R, Howbert, J J

    Published in The Journal of urology (01-02-1992)
    “…LY181984 is a compound in a series of orally active diarylsulfonylureas with broad spectrum in vivo activity against syngeneic rodent and human xenograft tumor…”
    Get more information
    Journal Article
  15. 15

    Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration by Sikes, R A, Thomsen, S, Petrow, V, Neubauer, B L, Chung, L W

    Published in Biology of reproduction (01-08-1990)
    “…Mouse prostatic hyperplasia has been induced experimentally by implanting fetal urogenital sinus tissue into the prostate gland of syngeneic mice. We compared…”
    Get full text
    Journal Article
  16. 16

    Bradykinin-induced contractions of canine prostate and bladder: effect of angiotensin-converting enzyme inhibition by Steidle, C P, Cohen, M L, Neubauer, B L

    Published in The Journal of urology (01-08-1990)
    “…Alpha-adrenergic, cholinergic, and serotonergic receptor-mediated contractile responses have been well characterized in the genitourinary tissues of several…”
    Get more information
    Journal Article
  17. 17

    Selective estrogen receptor modulators for the chemoprevention of prostate cancer by Steiner, Mitchell S, Raghow, Sharan, Neubauer, Blake L

    Published in Urology (Ridgewood, N.J.) (01-04-2001)
    “…The ability to interfere with prostate carcinogenesis, and as a consequence, prevent prostate cancer with drugs is the basis for chemoprevention. The prostate…”
    Get full text
    Journal Article
  18. 18

    Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat by Neubauer, B L, Best, K L, Clemens, J A, Gates, C A, Goode, R L, Jones, C D, Laughlin, M E, Shaar, C J, Toomey, R E, Hoover, D M

    Published in The Prostate (1993)
    “…The benzothiophene anti-estrogen, raloxifene [LY156758; (6-hydroxy-2-(4-hydroxyphenyl) benzo(b)thien-3-yl)(4-(2-1-piperidinyl)ethoxy)phenyl methanone…”
    Get more information
    Journal Article
  19. 19

    Recombinant DNA-derived human insulin-like growth factor II (hIGF-II) stimulates growth in hypophysectomized rats by Shaar, C J, Tinsley, F C, Smith, M C, Clemens, J A, Neubauer, B L

    Published in Endocrine research (1989)
    “…Sustained subcutaneous administration of recombinant DNA-derived insulin-like growth factor II to immature female hypophysectomized rats stimulated significant…”
    Get more information
    Journal Article
  20. 20

    LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male rats by Neubauer, B L, Best, K L, Blohm, T R, Gates, C, Goode, R L, Hirsch, K S, Laughlin, M E, Petrow, V, Smalstig, E B, Stamm, N B

    Published in The Prostate (1993)
    “…LY207320 is an in vitro inhibitor (estimated IC50 = 0.06 microM) of steroid 5 alpha-reductase that catalyzes the conversion of testosterone (T) to…”
    Get more information
    Journal Article